These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 37149826

  • 21. Cellular prion protein as a therapeutic target in Alzheimer's disease.
    Laurén J.
    J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
    [Abstract] [Full Text] [Related]

  • 22. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
    Um JW, Strittmatter SM.
    Prion; 2013; 7(1):37-41. PubMed ID: 22987042
    [Abstract] [Full Text] [Related]

  • 23. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y, Gong Y, Luan Y, Li Y, Liu J, Yue Z, Yuan B, Sun J, Xie C, Li L, Zhen J, Jin X, Zheng Y, Wang X, Xie L, Wang W.
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-PrPC antibody rescues cognition and synapses in transgenic alzheimer mice.
    Cox TO, Gunther EC, Brody AH, Chiasseu MT, Stoner A, Smith LM, Haas LT, Hammersley J, Rees G, Dosanjh B, Groves M, Gardener M, Dobson C, Vaughan T, Chessell I, Billinton A, Strittmatter SM.
    Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579
    [Abstract] [Full Text] [Related]

  • 29. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A, Santilli F, Martellucci S, Carbone E, Sorice M, Piscopo P, Mattei V.
    J Alzheimers Dis; 2022 Mar; 85(2):503-518. PubMed ID: 34864675
    [Abstract] [Full Text] [Related]

  • 30. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease.
    DeBay DR, Reid GA, Macdonald IR, Mawko G, Burrell S, Martin E, Bowen CV, Darvesh S.
    Brain Res; 2017 Sep 15; 1671():102-110. PubMed ID: 28729192
    [Abstract] [Full Text] [Related]

  • 31. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity.
    Maciejewski A, Ostapchenko VG, Beraldo FH, Prado VF, Prado MA, Choy WY.
    Biochem J; 2016 Jul 15; 473(14):2119-30. PubMed ID: 27208175
    [Abstract] [Full Text] [Related]

  • 32. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L, Ohno M.
    Transl Psychiatry; 2015 May 05; 5(5):e562. PubMed ID: 25942043
    [Abstract] [Full Text] [Related]

  • 33. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
    Gunther EC, Smith LM, Kostylev MA, Cox TO, Kaufman AC, Lee S, Folta-Stogniew E, Maynard GD, Um JW, Stagi M, Heiss JK, Stoner A, Noble GP, Takahashi H, Haas LT, Schneekloth JS, Merkel J, Teran C, Naderi ZK, Supattapone S, Strittmatter SM.
    Cell Rep; 2019 Jan 02; 26(1):145-158.e8. PubMed ID: 30605671
    [Abstract] [Full Text] [Related]

  • 34. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
    Peters C, Espinoza MP, Gallegos S, Opazo C, Aguayo LG.
    Neurobiol Aging; 2015 Mar 02; 36(3):1369-77. PubMed ID: 25599875
    [Abstract] [Full Text] [Related]

  • 35. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
    Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, Strittmatter SM.
    J Neurosci; 2010 May 05; 30(18):6367-74. PubMed ID: 20445063
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH, Yokotsuka M, Tobiume M, Sato Y, Hasegawa H, Nagao T, Gouras GK.
    Brain Pathol; 2021 Sep 05; 31(5):e12941. PubMed ID: 33624334
    [Abstract] [Full Text] [Related]

  • 38. Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.
    Jian M, Kwan JS, Bunting M, Ng RC, Chan KH.
    J Neuroinflammation; 2019 May 25; 16(1):110. PubMed ID: 31128596
    [Abstract] [Full Text] [Related]

  • 39. Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β Oligomers.
    Kostylev MA, Tuttle MD, Lee S, Klein LE, Takahashi H, Cox TO, Gunther EC, Zilm KW, Strittmatter SM.
    Mol Cell; 2018 Nov 01; 72(3):426-443.e12. PubMed ID: 30401430
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y, Zhang Y, Chen Q, Liu Y, Wei X, Wu M, Zhang K, Liu Y, Wei W.
    J Alzheimers Dis; 2023 Nov 01; 91(3):1197-1214. PubMed ID: 36565127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.